vs
エー・オー・スミス（AOS）とEncompass Health Corp（EHC）の財務データ比較。上の社名をクリックして会社を切り替えられます
Encompass Health Corpの直近四半期売上が大きい（$1.5B vs $912.5M、エー・オー・スミスの約1.7倍）。エー・オー・スミスの純利益率が高く（13.7% vs 9.5%、差は4.3%）。Encompass Health Corpの前年同期比売上増加率が高い（9.9% vs 0.0%）。エー・オー・スミスの直近四半期フリーキャッシュフローが多い（$165.5M vs $116.7M）。過去8四半期でEncompass Health Corpの売上複合成長率が高い（8.3% vs -3.4%）
A・O・スミスコーポレーションは米国発祥の住宅用・業務用給湯器とボイラーのメーカーで、北米で最大規模の給湯器製造・販売企業です。アジア市場では水処理・浄水製品も提供しており、世界に27拠点を持ち、北米に5か所の製造施設、インド・バンガロール、中国・南京、オランダ・フェルトホーフェンにも工場を構えています。
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
AOS vs EHC — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $912.5M | $1.5B |
| 純利益 | $125.4M | $146.1M |
| 粗利率 | 38.4% | — |
| 営業利益率 | 17.9% | 16.7% |
| 純利益率 | 13.7% | 9.5% |
| 売上前年比 | 0.0% | 9.9% |
| 純利益前年比 | 14.3% | 20.8% |
| EPS（希薄化後） | $0.89 | $1.43 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $912.5M | $1.5B | ||
| Q3 25 | $942.5M | $1.5B | ||
| Q2 25 | $1.0B | $1.5B | ||
| Q1 25 | $963.9M | $1.5B | ||
| Q4 24 | $912.4M | $1.4B | ||
| Q3 24 | $902.6M | $1.4B | ||
| Q2 24 | $1.0B | $1.3B | ||
| Q1 24 | $978.8M | $1.3B |
| Q4 25 | $125.4M | $146.1M | ||
| Q3 25 | $132.0M | $126.5M | ||
| Q2 25 | $152.2M | $142.1M | ||
| Q1 25 | $136.6M | $151.5M | ||
| Q4 24 | $109.7M | $120.9M | ||
| Q3 24 | $120.1M | $108.2M | ||
| Q2 24 | $156.2M | $114.1M | ||
| Q1 24 | $147.6M | $112.5M |
| Q4 25 | 38.4% | — | ||
| Q3 25 | 38.7% | — | ||
| Q2 25 | 39.3% | — | ||
| Q1 25 | 38.9% | — | ||
| Q4 24 | 37.1% | — | ||
| Q3 24 | 37.4% | — | ||
| Q2 24 | 38.7% | — | ||
| Q1 24 | 39.3% | — |
| Q4 25 | 17.9% | 16.7% | ||
| Q3 25 | 18.6% | 14.9% | ||
| Q2 25 | 20.4% | 16.2% | ||
| Q1 25 | 19.1% | 16.4% | ||
| Q4 24 | 10.1% | 14.3% | ||
| Q3 24 | 19.5% | 13.6% | ||
| Q2 24 | 21.9% | 14.3% | ||
| Q1 24 | 22.0% | 13.6% |
| Q4 25 | 13.7% | 9.5% | ||
| Q3 25 | 14.0% | 8.6% | ||
| Q2 25 | 15.0% | 9.7% | ||
| Q1 25 | 14.2% | 10.4% | ||
| Q4 24 | 12.0% | 8.6% | ||
| Q3 24 | 13.3% | 8.0% | ||
| Q2 24 | 15.2% | 8.8% | ||
| Q1 24 | 15.1% | 8.5% |
| Q4 25 | $0.89 | $1.43 | ||
| Q3 25 | $0.94 | $1.24 | ||
| Q2 25 | $1.07 | $1.39 | ||
| Q1 25 | $0.95 | $1.48 | ||
| Q4 24 | $0.75 | $1.18 | ||
| Q3 24 | $0.82 | $1.06 | ||
| Q2 24 | $1.06 | $1.12 | ||
| Q1 24 | $1.00 | $1.10 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $193.2M | $72.2M |
| 総負債低いほど良い | $155.0M | $2.4B |
| 株主資本純資産 | $1.9B | $2.4B |
| 総資産 | $3.1B | $7.1B |
| 負債/資本比率低いほどレバレッジが低い | 0.08× | 1.00× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $193.2M | $72.2M | ||
| Q3 25 | $172.8M | $48.7M | ||
| Q2 25 | $177.9M | $99.1M | ||
| Q1 25 | $200.2M | $95.8M | ||
| Q4 24 | $276.1M | $85.4M | ||
| Q3 24 | $255.6M | $147.8M | ||
| Q2 24 | $233.3M | $154.4M | ||
| Q1 24 | $303.1M | $134.4M |
| Q4 25 | $155.0M | $2.4B | ||
| Q3 25 | — | $2.4B | ||
| Q2 25 | — | $2.3B | ||
| Q1 25 | — | $2.3B | ||
| Q4 24 | $193.2M | $2.4B | ||
| Q3 24 | — | $2.3B | ||
| Q2 24 | — | $2.7B | ||
| Q1 24 | — | $2.7B |
| Q4 25 | $1.9B | $2.4B | ||
| Q3 25 | $1.8B | $2.4B | ||
| Q2 25 | $1.8B | $2.3B | ||
| Q1 25 | $1.9B | $2.2B | ||
| Q4 24 | $1.9B | $2.1B | ||
| Q3 24 | $1.9B | $2.0B | ||
| Q2 24 | $1.9B | $1.8B | ||
| Q1 24 | $1.9B | $1.7B |
| Q4 25 | $3.1B | $7.1B | ||
| Q3 25 | $3.2B | $6.9B | ||
| Q2 25 | $3.2B | $6.8B | ||
| Q1 25 | $3.3B | $6.6B | ||
| Q4 24 | $3.2B | $6.5B | ||
| Q3 24 | $3.2B | $6.5B | ||
| Q2 24 | $3.2B | $6.4B | ||
| Q1 24 | $3.2B | $6.2B |
| Q4 25 | 0.08× | 1.00× | ||
| Q3 25 | — | 1.01× | ||
| Q2 25 | — | 1.02× | ||
| Q1 25 | — | 1.08× | ||
| Q4 24 | 0.10× | 1.14× | ||
| Q3 24 | — | 1.20× | ||
| Q2 24 | — | 1.46× | ||
| Q1 24 | — | 1.54× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $183.1M | $346.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $165.5M | $116.7M |
| FCFマージンFCF / 売上 | 18.1% | 7.6% |
| 設備投資強度設備投資 / 売上 | 1.9% | 14.8% |
| キャッシュ転換率営業CF / 純利益 | 1.46× | 2.37× |
| 直近12ヶ月FCF直近4四半期 | $546.0M | $439.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $183.1M | $346.0M | ||
| Q3 25 | $255.4M | $270.8M | ||
| Q2 25 | $139.6M | $270.2M | ||
| Q1 25 | $38.7M | $288.6M | ||
| Q4 24 | $221.9M | $278.8M | ||
| Q3 24 | $195.9M | $267.8M | ||
| Q2 24 | $57.4M | $217.4M | ||
| Q1 24 | $106.6M | $238.8M |
| Q4 25 | $165.5M | $116.7M | ||
| Q3 25 | $240.6M | $83.7M | ||
| Q2 25 | $122.5M | $113.3M | ||
| Q1 25 | $17.4M | $125.5M | ||
| Q4 24 | $191.3M | $80.1M | ||
| Q3 24 | $163.4M | $120.3M | ||
| Q2 24 | $34.5M | $60.5M | ||
| Q1 24 | $84.6M | $99.4M |
| Q4 25 | 18.1% | 7.6% | ||
| Q3 25 | 25.5% | 5.7% | ||
| Q2 25 | 12.1% | 7.8% | ||
| Q1 25 | 1.8% | 8.6% | ||
| Q4 24 | 21.0% | 5.7% | ||
| Q3 24 | 18.1% | 8.9% | ||
| Q2 24 | 3.4% | 4.6% | ||
| Q1 24 | 8.6% | 7.6% |
| Q4 25 | 1.9% | 14.8% | ||
| Q3 25 | 1.6% | 12.7% | ||
| Q2 25 | 1.7% | 10.8% | ||
| Q1 25 | 2.2% | 11.2% | ||
| Q4 24 | 3.4% | 14.1% | ||
| Q3 24 | 3.6% | 10.9% | ||
| Q2 24 | 2.2% | 12.1% | ||
| Q1 24 | 2.2% | 10.6% |
| Q4 25 | 1.46× | 2.37× | ||
| Q3 25 | 1.93× | 2.14× | ||
| Q2 25 | 0.92× | 1.90× | ||
| Q1 25 | 0.28× | 1.90× | ||
| Q4 24 | 2.02× | 2.31× | ||
| Q3 24 | 1.63× | 2.48× | ||
| Q2 24 | 0.37× | 1.91× | ||
| Q1 24 | 0.72× | 2.12× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AOS
| North America Segment | $713.7M | 78% |
| Rest Of World | $158.3M | 17% |
| Other | $40.5M | 4% |
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
